Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

100% Upside on these Bio-techs
Motley Fool
Sunday, February 3, 2013 - 11:26am
tags:
Galena Biopharma, NeuVax, MannKind, Afrezza
This Week in Biotech
Motley Fool
Sunday, February 3, 2013 - 11:23am
tags:
Keryx, Vanda, Repros Therapeutics, Celsion, Zoetis
Aegerion Pharmaceuticals Expected To Take A Hit
Seeking Alpha
Saturday, February 2, 2013 - 12:05pm
tags:
Aegerion
Medical Industry Must Disclose Doctor Payments, U.S. Says
Bloomberg
Saturday, February 2, 2013 - 12:04pm
tags:
Affordable Care Act
Zoetis Plans to Keep Factories as It Seeks New Products
Bloomberg
Saturday, February 2, 2013 - 12:03pm
tags:
Zoetis
Pfizer, Bristol-Myers, Johnson And Johnson: Do They Have The Next Plavix, Or Vioxx?
Seeking Alpha
Saturday, February 2, 2013 - 12:02pm
tags:
JNJ, Bristol-Myers Squibb, Pfizer
Faruqi & Faruqi, LLP Files Class Action Lawsuit Against Keryx Biopharmaceuticals, Inc.
Yahoo/PR Newswire
Saturday, February 2, 2013 - 12:00pm
tags:
Keryx, lawsuit
Animal Health Firm Zoetis Is Biggest IPO Since Facebook
Motley Fool
Saturday, February 2, 2013 - 11:59am
tags:
Zoetis
Keryx shares more than doubles on kidney drug data
Yahoo/AP
Saturday, February 2, 2013 - 11:56am
tags:
Keryx, Zerenex, kidney disease
Dendreon: The Median Is Not The Average
Seeking Alpha
Saturday, February 2, 2013 - 11:49am
tags:
Dendreon
Gilead Sciences: A Great Long-Term Buy And Heading Bullishly Into Earnings
Seeking Alpha
Saturday, February 2, 2013 - 11:49am
tags:
Gilead, earnings
Celsion Stock Blown Apart On Thermodox Phase III Data
Seeking Alpha
Saturday, February 2, 2013 - 11:48am
tags:
Celsion, ThermoDox, hepatocellular carcinoma
BGI-Shenzhen Extends Tender Offer for Complete Genomics, Inc.
Yahoo/PR Newswire
Saturday, February 2, 2013 - 11:47am
tags:
BGI-Shenzhen, Complete Genomics, M&A
4 Healthcare Stock Stories for TGIF Wellness
Wall Street Cheat Street
Saturday, February 2, 2013 - 11:46am
tags:
Vertex Pharmaceuticals, Seattle Genetics, Echo Therapeutics, Santarus
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, February 2, 2013 - 11:44am
tags:
Celsion, Herbalife, Halozyme
Vivus up on heart drug study
Investors Business Daily
Saturday, February 2, 2013 - 11:44am
tags:
Vivus, Qsymia, Anti-Hypertension
NTS launches tax probe into Dong-A Pharmaceutical
Yonhap News, South Korea
Saturday, February 2, 2013 - 11:42am
tags:
Dong-A Pharma
50 Jaw-Dropping Pharmaceutical, Biotech, and Life Science Statistics
Motley Fool
Saturday, February 2, 2013 - 11:41am
tags:
Gilead Sciences Earnings: An Early Look
Motley Fool
Saturday, February 2, 2013 - 11:40am
tags:
Gilead Sciences
3 Biotechs Burning Through Cash
Motley Fool
Saturday, February 2, 2013 - 11:39am
tags:
Peregrine Pharmaceuticals, Ziopharm, Keryx

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.